Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder. [electronic resource]
Producer: 20140501Description: 464-9 p. digitalISSN:- 1473-1150
- Antidepressive Agents -- therapeutic use
- Anxiety Disorders -- drug therapy
- Biomarkers, Pharmacological -- metabolism
- Cyclohexanols -- therapeutic use
- Double-Blind Method
- Haplotypes
- Humans
- Pharmacogenetics -- methods
- Polymorphism, Single Nucleotide
- Receptor, Serotonin, 5-HT2A -- genetics
- Serotonin Plasma Membrane Transport Proteins -- genetics
- Venlafaxine Hydrochloride
- White People -- genetics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.